TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Total Assets (Quarterly) : 37.53M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.53M |
| March 31, 2026 | 37.58M |
| December 31, 2025 | 37.66M |
| September 30, 2025 | 38.67M |
| June 30, 2025 | 38.50M |
| March 31, 2025 | 38.24M |
| December 31, 2024 | 38.82M |
| September 30, 2024 | 39.55M |
| June 30, 2024 | 40.13M |
| March 31, 2024 | 42.09M |
| December 31, 2023 | 43.31M |
| September 30, 2023 | 50.49M |
| June 30, 2023 | 53.69M |
| March 31, 2023 | 59.60M |
| December 31, 2022 | |
| September 30, 2022 | 133.91M |
| June 30, 2022 | 146.20M |
| March 31, 2022 | 133.38M |
| December 31, 2021 | 169.47M |
| September 30, 2021 | 209.63M |
| June 30, 2021 | 210.60M |
| March 31, 2021 | 239.31M |
| December 31, 2020 | 181.61M |
| September 30, 2020 | 177.29M |
| June 30, 2020 | 205.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 268.64M |
| December 31, 2019 | 265.99M |
| September 30, 2019 | 249.96M |
| June 30, 2019 | 246.55M |
| March 31, 2019 | 181.89M |
| December 31, 2018 | 211.98M |
| September 30, 2018 | 236.75M |
| June 30, 2018 | 171.90M |
| March 31, 2018 | 122.96M |
| December 31, 2017 | 143.23M |
| September 30, 2017 | 160.36M |
| June 30, 2017 | 106.88M |
| March 31, 2017 | 124.42M |
| December 31, 2016 | 142.47M |
| September 30, 2016 | 158.82M |
| June 30, 2016 | 176.59M |
| March 31, 2016 | 192.97M |
| December 31, 2015 | 73.73M |
| September 30, 2015 | 90.46M |
| June 30, 2015 | 75.68M |
| March 31, 2015 | 99.48M |
| December 31, 2014 | 59.08M |
| September 30, 2014 | 74.61M |
| June 30, 2014 | 44.43M |
| March 31, 2014 | 53.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.40M |
| Shareholders Equity (Quarterly) | 27.13M |
| Debt to Equity Ratio | 0.2049 |
| Current Ratio | 2.756 |
| Net Debt Paydown Yield | 1.10% |